(Q34647540)

3 August 2017

Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Edwards KR

1

1 reference

PubMed ID

11903525

3 August 2017

Norton J

series ordinal

2

1 reference

PubMed ID

11903525

3 August 2017

Behnke M

series ordinal

3

1 reference

3 August 2017

1 November 2001

1 reference

3 August 2017

1 reference

3 August 2017

41

1 reference

3 August 2017

10

1 reference

3 August 2017

976-980

1 reference

Burden of migraine in the United States: disability and economic costs.

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Cardiac arrest following use of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Analgesic rebound headache. How great is the problem and what can be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

The safety of rapid valproic acid infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2001.01191.X

10.1046/J.1526-4610.2001.01191.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11903525